Group B streptococcal conjugate vaccine (Baxter International)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGroup B streptococcal conjugate vaccine (Baxter International)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsStreptococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHarvard University Baxter International Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe Brigham and Women's Hospital Harvard University Baxter International Inc

Active IndicationsN/A

Inactive IndicationsStreptococcal Infections

Other Information

ATC CodeN/A